Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of “Moderate Buy” from Brokerages

Posted by Francis Steltz on Sep 30th, 2026

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen analysts that are currently covering the company, Marketbeat.com reports. Seven analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $22.23.

SBRA has been the topic of a number of research analyst reports. Scotiabank reduced their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Mizuho set a $21.00 price target on Sabra Healthcare REIT in a report on Monday, August 31st. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Huntington initiated coverage on Sabra Healthcare REIT in a research note on Thursday, September 10th. They set an “outperform” rating and a $23.00 price objective on the stock. Finally, Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd.

Get Our Latest Analysis on SBRA

Insider Activity

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. The trade was a 10.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company’s stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

Large investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. raised its stake in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares in the last quarter. Nissay Asset Management Corp Japan lifted its holdings in Sabra Healthcare REIT by 1.5% in the 2nd quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock worth $760,000 after purchasing an additional 585 shares during the last quarter. Versant Capital Management Inc boosted its position in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the period. IFP Advisors Inc boosted its position in Sabra Healthcare REIT by 14.3% during the fourth quarter. IFP Advisors Inc now owns 5,715 shares of the real estate investment trust’s stock worth $108,000 after purchasing an additional 717 shares during the period. Finally, Silver Oak Securities Incorporated grew its holdings in Sabra Healthcare REIT by 2.9% during the first quarter. Silver Oak Securities Incorporated now owns 25,855 shares of the real estate investment trust’s stock valued at $497,000 after purchasing an additional 725 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.2%

NASDAQ:SBRA opened at $19.78 on Friday. The business’s 50-day moving average is $20.67 and its two-hundred day moving average is $20.16. The firm has a market capitalization of $5.05 billion, a PE ratio of 76.08, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65. Sabra Healthcare REIT has a 12 month low of $17.17 and a 12 month high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. During the same period in the previous year, the firm posted $0.38 earnings per share. The company’s revenue for the quarter was up 24.7% on a year-over-year basis. Research analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s payout ratio is currently 461.54%.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.